Literature DB >> 15714161

Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress.

Yau-Lin Tseng1, Yan-Lin Tseng, David H Sachs, David K C Cooper.   

Abstract

The critical shortage of human donor organs for transplantation would be overcome if a suitable animal, e.g., the pig, could be used as an organ source. There are, however, several immune barriers that have to date resulted in limited function of pig organs transplanted into nonhuman primates. It would be beneficial, and indeed may be essential, to induce a state of tolerance in the primate recipient to the pig organ. In allotransplantation, the successful transplantation of hematopoietic progenitor cells with the development of mixed chimerism is associated with the induction of tolerance toward a donor-specific organ. For some years, this approach has been explored in the pig-to-nonhuman primate model. This experience is briefly reviewed. The problems of natural and elicited anti-pig antibodies, recipient platelet adhesion to pig hematopietic progenitor cells, and the rapid removal of these cells by the host macrophage-phagocytic system are highlighted. Recent experience with the use of hematopoietic cells from pigs homozygous for alpha1,3-galactosyltransferase gene-knockout is reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714161     DOI: 10.1097/01.tp.0000146504.73727.13

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.

Authors:  Adam Griesemer; Fan Liang; Atsushi Hirakata; Erica Hirsh; Diana Lo; Masayoshi Okumi; Megan Sykes; Kazuhiko Yamada; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

2.  Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.

Authors:  Kentaro Ide; Hui Wang; Hiroyuki Tahara; Jianxiang Liu; Xiaoying Wang; Toshimasa Asahara; Megan Sykes; Yong-Guang Yang; Hideki Ohdan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

Review 3.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

Review 4.  New concepts of immune modulation in xenotransplantation.

Authors:  Vikas Satyananda; Hidetaka Hara; Mohamed B Ezzelarab; Carol Phelps; David Ayares; David K C Cooper
Journal:  Transplantation       Date:  2013-12-15       Impact factor: 4.939

5.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

Review 6.  Immunobiological barriers to xenotransplantation.

Authors:  David K C Cooper; Burcin Ekser; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-06       Impact factor: 6.071

7.  Frankenswine, or bringing home the bacon: How close are we to clinical trials in xenotransplantation?

Authors:  David Kc Cooper
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

Review 8.  Modifying the sugar icing on the transplantation cake.

Authors:  David K C Cooper
Journal:  Glycobiology       Date:  2016-03-01       Impact factor: 4.313

Review 9.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons.

Authors:  Y Hisashi; K Yamada; K Kuwaki; Y-L Tseng; F J M F Dor; S L Houser; S C Robson; H-J Schuurman; D K C Cooper; D H Sachs; R B Colvin; A Shimizu
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.